Antibiotic resistance and serotype distribution of Shigella strains in Bangladesh over the period of 2014–2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases
Microbiology Spectrum · 05.12.2024 · 12 (12)
DOI: 10.1128/spectrum.00739-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 05.12.2024. Verfasst von Mokibul Hassan Afrad und 12 weiteren Autor:innen. Beteiligte Einrichtung: International Centre for Diarrheal Disease Research Bangladesh, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Dysentery, Bacillary, Shigella, Anti-Bacterial Agents, Diarrhea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, NIAID NIH HHS, Bill and Melinda Gates Foundation (GF).
Abstract (Originalsprache)
The objective of this study was to assess the prevalence, antimicrobial resistance patterns, and risk factors linked to Shigella infections through a nationwide hospital-based diarrheal disease surveillance in Bangladesh. From May 2014 to May 2022, from a systematic sentinel surveillance of Shigella infections in over 10 hospitals across Bangladesh, stool specimens were collected from patients with acute watery diarrhea and tested for Shigella species by microbiological culture. The susceptibility to antibiotics was tested using the disk diffusion method. Structured questionnaires were used to collect participants’ socioeconomic status and clinical, sanitation, and food history. Out of 24,357 stool specimens, 1.8% were positive for Shigella species, with a higher prevalence among males (58%). Children in the 6–17 age group were found to be at the highest risk of Shigella infections. The most prevalent serotype was Shigella flexneri (79.5%), followed by Shigella sonnei. S. flexneri serotype 2a was the most common (63.3%) among all Shigella serotypes. Antibiotic susceptibility testing showed over 99% of isolates resistant or with intermediate susceptibility to one of the seven antibiotics tested. About 96% of S. flexneri and all S. sonnei isolates demonstrated resistance to at least one quinolone class of antibiotics, particularly ciprofloxacin or nalidixic acid. S. sonnei showed higher antibiotic resistance and multidrug resistance compared to S. flexneri . The high level of resistance to ciprofloxacin highlights the need for more prudent use of this antibiotic and improved hygiene and sanitation. The study emphasized the importance of regular monitoring of drug resistance to effectively manage Shigella infections. These findings may provide the epidemiological evidence for conducting future appropriate Shigella vaccine clinical trials in Bangladesh. IMPORTANCE This nationwide study in Bangladesh assessed Shigella infections from 2014 to 2022 from clinical samples. S. flexneri was predominant, with concerning antibiotic resistance, notably to ciprofloxacin and nalidixic acid in over 96% of isolates. This emphasizes the urgency of prudent antibiotic use and improved hygiene. The findings provide crucial antimicrobial resistance patterns of Shigella species, highlighting the need for ongoing resistance monitoring and potentially informing future vaccine trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Centre for Diarrheal Disease Research Bangladesh, Dhaka, Bangladesh.
- Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.
- Department of Medicine, Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Mokibul Hassan Afrad, Taufiqur Rahman Bhuiyan, Edward T Ryan, Firdausi Qadri
Förderung
- FIC NIH HHS
- NIAID NIH HHS
- Bill and Melinda Gates Foundation (GF)
Zitieren
APA
Afrad, M. H., Islam, M. T., Begum, Y. A., Saifullah, M., Ahmmed, F., Khan, Z. H., Habib, Z. H., Alam, A. N., Shirin, T., Bhuiyan, T. R., Ryan, E. T., Khan, A. I., & Qadri, F. (2024). Antibiotic resistance and serotype distribution of Shigella strains in Bangladesh over the period of 2014–2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases. Microbiology Spectrum, 12(12). https://doi.org/10.1128/spectrum.00739-24
Vancouver
Afrad MH, Islam MT, Begum YA, Saifullah M, Ahmmed F, Khan ZH, et al. Antibiotic resistance and serotype distribution of Shigella strains in Bangladesh over the period of 2014–2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases. Microbiology Spectrum. 2024;12(12). doi:10.1128/spectrum.00739-24
BibTeX
@article{Afrad2024,
author = {Afrad, Mokibul Hassan and Islam, Md Taufiqul and Begum, Yasmin Ara and Saifullah, Md and Ahmmed, Faisal and Khan, Zahid Hasan and Habib, Zakir Hossain and Alam, Ahmed Nawsher and Shirin, Tahmina and Bhuiyan, Taufiqur Rahman and Ryan, Edward T and Khan, Ashraful Islam and Qadri, Firdausi},
title = {Antibiotic resistance and serotype distribution of Shigella strains in Bangladesh over the period of 2014–2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases},
journal = {Microbiology Spectrum},
year = {2024},
volume = {12},
number = {12},
doi = {10.1128/spectrum.00739-24}
}
EUVIMED